<DOC>
	<DOCNO>NCT02808182</DOCNO>
	<brief_summary>Lipotoxicity-causing fatty acid overexposure accretion lean tissue lead insulin resistance impair pancreatic Î²-cell function - hallmark T2D - contributing associate complication heart failure , kidney failure microvascular disease . Proper dietary fatty acid ( DFA ) storage white adipose tissue ( WAT ) think prevent lean-tissue lipotoxicity . Using novel Positron-Emission Tomography ( PET ) stable isotopic tracer method develop Sherbrooke , investigator show WAT storage DFA impaired people pre-diabetes T2D . The investigator also show impairment associate great cardiac DFA uptake , well subclinical left-ventricular systolic diastolic dysfunction . Then , It find modest weight loss pre-diabetics , one-year lifestyle intervention , improve WAT DFA storage , curb cardiac DFA uptake , restore associate left-ventricular dysfunction . It also find 7-day low-saturated fat , low-calorie diet raise insulin sensitivity restore WAT cardiac DFA metabolism . Whether WAT DFA storage directly impact cardiac DFA uptake know . Importantly , investigator recently uncover marked sex-specific difference WAT DFA metabolism . These may explain , least part , sex-related difference cardiac DFA uptake , occur pre-diabetes . Higher spillover WAT DFA circulate Non-Esterified Fatty Acid ( NEFA ) appear link woman great cardiac DFA uptake , oppose direct cardiac chylomicron triglyceride ( TG ) uptake men . Here , investigator isolate compare organ-specific fatty acid uptake occur postprandially chylomicron-TG vs. NEFA pool , well oxidative vs. non-oxidative intracellular metabolic pathway associate increased cardiac DFA uptake pre-diabetic men woman .</brief_summary>
	<brief_title>Postprandial Fatty Acid Metabolism Natural History Type 2 Diabetes ( T2D )</brief_title>
	<detailed_description />
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>For healthy subject : fast glucose &lt; 5.6 , 2hour post 75g Oral Glucose Tolerance Test ( OGTT ) glucose &lt; 7.8 mmol/l HbA1c &lt; 5.8 % For subject glucose intolerance ( IGT ) : 2hour post 75g OGTT glucose 7.811.1 mmol/l two separate occasion HbA1c 6.0 6.4 % overt cardiovascular disease assess medical history , physical exam , abnormal ECG treatment fibrate , thiazolidinedione , betablocker drug know affect lipid carbohydrate metabolism ( except statin , metformin , antihypertensive agent safely interrupt ) presence liver renal disease , uncontrolled thyroid disorder , previous pancreatitis , bleed disorder , major illness smoking ( &gt; 1 cigarette/day ) and/or consumption &gt; 2 alcoholic beverage per day prior history current fasting plasma cholesterol level &gt; 7 mmol/l fast TG &gt; 6 mmol/l contraindication temporarily interrupt current med lipid hypertension pregnant barren</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>